- FDA Approves Bijuva (estradiol and progesterone) Capsules for the Treatment of Moderate to Severe Vasomotor Symptoms Due to Menopause - October 29, 2018
- TherapeuticsMD Announces FDA Acceptance of New Drug Application (NDA) and Prescription Drug User Fee Act (PDUFA) Date for TX-001HR - March 8, 2018
- TherapeuticsMD Announces Submission of New Drug Application for TX-001HR - December 28, 2017
Drugs Associated with TherapeuticsMD, Inc.
TherapeuticsMD, Inc. manufactures, markets and/or distributes more than 2 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
Generic name: estradiol/progesterone
Drug class: sex hormone combinations
|20 reviews||5.2 / 10|
Generic name: estradiol
Drug class: estrogens, miscellaneous vaginal agents
|46 reviews||5.1 / 10|
|For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).|